HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-07-06Clinical Trial Update: Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV [Phase 2]
Phase 2 clinical trial evaluating peg-Interferon-α2b to decrease viral DNA in HIV-1 infection has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Single-Dose Islatravir in Moderate Hepatic Impairment (MK-8591-030) [Phase 1]
Phase 1 MK-8591-030 reports results for a single-dose islatravir in individuals with moderate hepatic impairment; the study is completed and…
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Boston ARCH 4F Intervention to Reduce Fall Risk in People With HIV and Alcohol Use [NA]
A completed clinical trial (NCT04804579) investigating a 4F intervention to reduce fall risk in people with HIV and alcohol use; results pos…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection [Phase 1, Phase 2]
Clinical trial update on the efficacy of VHM after treatment interruption in people initiating ART during acute HIV infection; phases 1 and …
-
FDA approval · 2023-06-15FDA Approved: TRIUMEQ PD — Supplemental Application (ViiV Healthcare Company)
FDA approves a supplemental application for TRIUMEQ PD, the fixed-dose combination of abacavir sulfate, dolutegravir sodium, and lamivudine,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-06-15FDA Approved: TRIUMEQ — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for Triumeq, a fixed-dose combination of abacavir sulfate, dolutegravir sodium, and lamivudine, subm…
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: A Study of the Gut Barrier and Blood Vessel Inflammation in Individuals With and Without HIV [Phase 2]
A Phase 2 clinical trial assessing gut barrier integrity and vascular inflammation in individuals with HIV and without HIV; study completed …
-
CLINICAL_TRIALS research · 2023-06-09Clinical Trial Update: Enhancing Partner Services Among Men Who Have Sex With Men Living With HIV [NA]
A completed clinical trial from UNC Chapel Hill focusing on enhancing partner services among men who have sex with men living with HIV; resu…
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Providing Suboxone and PrEP Using Telemedicine [NA]
Completed clinical trial evaluating telemedicine provision of Suboxone and PrEP for opioid use disorder with results posted in 2023.
-
FDA approval · 2023-06-07FDA Approved: ABACAVIR AND LAMIVUDINE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for the abacavir and lamivudine fixed-dose combination from Cipla USA Inc., updating its labeling fo…
-
FDA approval · 2023-06-07FDA Approved: NEVIRAPINE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for Nevirapine from Macleods Pharmaceuticals Limited under ANDA090688.
-
FDA approval · 2023-06-07FDA Approved: NEVIRAPINE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved the supplemental application for NEVIRAPINE filed by Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: A Technology-Delivered Peer-to-Peer Support ART Adherence Intervention for Substance-using HIV+ Adults [NA]
Completed clinical trial evaluating a technology-delivered peer-to-peer support intervention to improve ART adherence in substance-using HIV…
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Effects of Eplerenone on Cardiovascular Disease in HIV (MIRACLE HIV Study) [NA]
A completed clinical trial evaluating the effects of eplerenone on cardiovascular disease in people with HIV.
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: FANMI: Community Cohort Care for HIV-Infected Adolescent Girls in Haiti [NA]
A completed clinical trial evaluating community-based care for HIV-infected adolescent girls in Haiti; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Therapeutic Vaccination in Treated HIV Disease [Phase 1, Phase 2]
A phase 1/2 clinical trial of a therapeutic vaccination in treated HIV infection has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-25Clinical Trial Update: Pharmacokinetics of Calcineurin & mTOR Inhibitors in HIV-1 Infected Kidney Transplant Recipients After Switch to BIC/FTC/TAF [Phase 4]
Phase 4 clinical trial update on pharmacokinetics of calcineurin and mTOR inhibitors in HIV-1 infected kidney transplant recipients after sw…
-
CLINICAL_TRIALS trial_result · 2023-05-23Clinical Trial Update: Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV [Phase 2]
Phase 2 study investigating a TLR9 agonist combined with broadly neutralizing antibodies to reduce HIV reservoirs and achieve immunological …
-
CLINICAL_TRIALS trial_result · 2023-05-22Clinical Trial Update: Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication [Phase 4]
Phase 4 trial updating cardiovascular risk outcomes after hepatitis C eradication in individuals with HIV and hepatitis C; results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-19Clinical Trial Update: Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals [Phase 1]
Phase 1 trial assessing safety and toxicity of Polyphenon E (EGCG) in HIV-1-infected individuals has completed with results posted.
-
FDA approval · 2023-05-12FDA Approved: EVOTAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for EVOTAZ (atazanavir and cobicistat) from E.R. Squibb & Sons, L.L.C.
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART) [Phase 1]
Phase 1 clinical trial evaluating effects of vorinostat and HXTC on persistent HIV-1 infection in patients on ART has completed with results…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis [Phase 4]
Phase 4 clinical trial evaluating switching to Emtricitabine/Tenofovir Alafenamide for HIV pre-exposure prophylaxis in transgender individua…
-
FDA approval · 2023-05-05FDA Approved: LAMIVUDINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for lamivudine by Apotex Corp., enabling the generic lamivudine product to be marketed.
-
FDA approval · 2023-05-01FDA Approved: BIKTARVY — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for BIKTARVY, submitted by Gilead Sciences, Inc.